China · Delayed Price · Currency is CNY Hebei Changshan Biochemical Pharmaceutical Company Description
Hebei Changshan Biochemical Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, marketing, and sale of drugs for cardiovascular, cerebrovascular, diabetes, and cancer in China and internationally.
It offers heparin sodium, calcium, and lithium, as well as heparinoid, LMW heparins, and sodium hyaluronate; dalteparin sodium, enoxaparin sodium, nadroparin calcium, and heparin sodium injections, as well as sildenafil citrate tablet; and albenatide.
The company is also involved in technology development; consulting; transfer services; investment and management of medical service projects; wholesale and retail of pharmaceuticals; and diagnosis services.
It exports its products to the United States, Germany, France, Italy, Spain, South Korea, Japan, Russia, India, the Philippines, and other countries.
The company was founded in 1992 and is based in Shijiazhuang, China.
| Country | China |
| Founded | 1992 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,194 |
| CEO | Xiaodong Gao |
Contact Details
Address: No. 71 Menglong Street, South Zone Shijiazhuang, Hebei Province 050800 China | |
| Phone | 86 311 8919 0181 |
| Website | hbcsbio.com |
Stock Details
| Ticker Symbol | 300255 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000016C2 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Xiaodong Gao | Chairman of the Board and GM |
| Xiaohua Yue | Deputy GM and Chief Financial Officer |
| Yunxia Sun | Deputy GM and Non-Independent Director |
| Zhenggang Qie | Deputy GM and Non-Independent Director |